The type III tumour microenvironment, defined as PD-L1 expression positivity and lack of T-cell infiltration, is the dominant type in ESCC (66.1%), indicating the need for an approach that comprises a combination of ICIs with promotion of cell infiltration in tumours [24]. Here, CD274 is linked to neoplasm.